The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Resisting the reality of chronic illness can lead to emotional distress. Acceptance, on the other hand, can open the door to ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

Advances in medical treatment for cardiovascular disease, a leading cause of death in the U.S., have helped patients live longer. But a new report finds that risk factors that lead to heart disease ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...